BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitin...( SAN ANTONIO June 16 /- BME (BioMe...),Health
Navigation Links
BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant
Date:6/16/2008
SAN ANTONIO, June 16 /PRNewswire/ -- BME (BioMedical Enterprises, Inc.), a privately held medical device company and leader in orthopaedic shape memory implant technology, today announced the launch of the Barbed OSStaple(TM) (BOSS), a nitinol implant designed for internal fixation of bone.
The BOSS is an orthopaedic nitinol implant with barbs on the legs for bone adhesion. Like the BME OSStaple(TM) product line, the BOSS nitinol staple changes shape when heated above body temperature to provide compression between two bones. The BOSS is ideal for upper and lower extremity procedures, especially when surgeons want the added security of barbed legs to stabilize the implant.
Made of nitinol, a biocompatible alloy possessing shape memory and super-elastic properties, the BOSS implant is inserted at room temperature. Using BME's patented OSSforce(TM) Implant Controller, the implant is safely heated above body temperature. During this process, the implant's legs and back change shape to compress bone. In addition, the movement of the legs causes the barbs to anchor more securely in bone. After heating, the nitinol structure transforms into a state approximately 20% stronger than 316L stainless steel. Due to nitinol's unique properties, the implant continues to maintain a compressive force in bone over time.
The BOSS implant, along with BME's OSSAnchor(TM) Grip soft tissue anchor, are the first orthopaedic nitinol implants to feature barbs for improved pull-out resistance, a new surface treatment that minimizes metal ion release, and a roughened surface texture for bone in-growth.
A national launch of the Barbed OSStaple(TM) will begin at the American Orthopaedic Foot and Ankle Society summer meeting in Denver, Colorado being held June 25-28.
BME is a medical device company that addresses the changing needs in
musculoskeletal medicine. BME focuses on minimally invasive orthopaedic
instrumentation and implants that elicit a biologi
'/>"/>
| SOURCE BioMedical Enterprises, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor
2. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
3. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
4. Coventina Healthcare Enterprises, Inc. is Now ReGear Life Sciences, Inc.
5. Supreme Court Hears Case on Federal Pre-emption of Safety Standards for Medical Technologies (Riegel v. Medtronic, Inc.)
6. CYNACON/OCuSOFT (OCuSOFT, Inc.) Names Katherine M. Mastrota, M.S., O.D. to Medical Scientific Advisory Board
7. IOF announces 3 orthopaedic sessions at 2008 congress
8. Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma
9. NightHawk Radiology Holdings, Inc. Announces Preliminary Results of Its Tender Offer; NightHawk Expects to Purchase 2,367,438 Shares of Its Common Stock at $8.05 per Share
10. Cardiva Medical, Inc. to Present at the Investment In Innovation (In3) Medical Device Summit on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion
11. Therap Services Announces Release 7.3 for the Developmental Disability Community
Post Your Comments:
(Date:11/20/2009)...ON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST P...l Meeting of Shareholders will be held on Monday, ...o consider approval of two special resolutions. Th...rize the sale of all or substantially all of the a...ded for in the asset purchase agreement dated Nove...
(Date:11/20/2009)...HINGTON, Nov. 20 The Un...he Senate to make essential changes its health ref...abortion funding and conscience protection on abor... and include strong provisions for adequate afford...h care bill an "enormous disappointment" that crea...
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-...alth Care Vote , Washingt...ongressmen running for re-election next year in ra...rlie Cook, may come to regret voting for House Spe...ing to a breaking Zogby International/ O’Lea...
(Date:11/20/2009)... Nov. 20 The American D...and Drug Administration (FDA) to establish appropr.... ,, Citing concern about the safety of whiten...he benefit of professional consultation or examina...pplication of chemically based tooth whitening or ...
(Date:11/20/2009)...AIFA, Israel, November 20 /PRNewswire-FirstCall/ -... http://www.CVSLMEDICAL.COM , a leading,developer ...ay announced that,the company,s Board of Directors...rope, Canada and the Far East for its proprietary ...or all angioplasty (PCTA) procedures. , C...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2[0] NUCRYST Announces Special Meeting of Shareholders[0] U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability[0] Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill [0] American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products[0] Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East
... new weapon is being investigated.//
Scientist...edient -oligo fructose, on obese human subjects. ...the natural fiber seen in baby foods, cereals and ...ke peptide that was responsible for a feeling of s...
...munication between clinicians in the Intensive Car... significantly reduces feelings of stress,// anxie...g to a study that appears in the February 1, 2007 ...National Institutes of Health (NIH), showed that t...
...vels during women’s menstrual cycles affect the re... imaging study at the National Institute of// Ment...itutes of Health (NIH), has revealed.
While w...o a phase when estrogen and progesterone are prese...
...to grant product patent for Glivec, the cancer dru...esult Novartis may not be able to conduct// their ...re the countries where Novartis conducts its resea... government could hamper the launch of their paten...
...re has been a marked increase in allergic reaction...ed eight times during a 30 year period.// Teenager...sporting different hair colors, in keeping with a ...esearchers are pressing for a wider debate about t...
...of Michigan Medical Center have, for the first tim.../ Their work indicates that these cells are likely...ression, and metastasis that define this deadly ca...atic cancer in half of mice tested. They also foun...
Other Medicine News:Health News:Communication in the ICU to Be Strengthened 2Health News:Communication in the ICU to Be Strengthened 3Health News:NIMH Studies Woman’s Hormonal Cycl 2Health News:Scientists Identify Pancreatic Cancer Stem Cells 2Health News:Scientists Identify Pancreatic Cancer Stem Cells 3(Date:11/20/2009)... , NEW YORK, Nov. 20 ,, Re...h report is available in its catalogue. ,, Glo... http://www.reportlinker.com/p0164741/Global-Mark...=prnewswire&utm_medium=pr&utm_campaign=prn...sy devices includes the spring loaded core needle ...
(Date:11/20/2009)..., NATICK, Mass. and LONDON, Nov. 20 /PRNewswire...: BSX ) today announced that it has received 510...ration (FDA) and CE Mark approval to market its Wa...e treatment of malignant esophageal strictures (ob...ctable or non-resectable esophageal cancer. ,,...
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire-U...mes article that questions why currently availabl...ancers are being ignored, ECRI Institute, an indep...ap to the evidence on Finasteride for Prevention ... November 13, 2009, New York Times article, " Dr...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Heartburn Drugs May Contribute to the Problem 50969 1Heartburn Drugs May Contribute to the Problem 50969 2Heartburn Drugs May Contribute to the Problem 50969 3Pharmacyclics Sets Record Date for Rights Offering 50966 1Pharmacyclics Sets Record Date for Rights Offering 50966 2Pharmacyclics Sets Record Date for Rights Offering 50966 3CareFusion Corporation Launches International Jazz Festival Series 50963 1CareFusion Corporation Launches International Jazz Festival Series 50963 2CareFusion Corporation Launches International Jazz Festival Series 50963 3CareFusion Corporation Launches International Jazz Festival Series 50963 4CareFusion Corporation Launches International Jazz Festival Series 50963 5[0] Reportlinker Adds Global Markets for Breast Biopsy Devices 2009[0] Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent[0] ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists
... (OTCBB: ORMP) ( http://www.oramed.com ), a develo... it will hold a conference call on August 6,2008 a... 2A clinical trials,of its flagship product, ORMD ... trial is focused on assessing the safety and effi... the successfully completed,Phase 1 studies in Isr...
...(OTC Bulletin Board: ANPG), reported today that it...I) announced that its EnviroTru(R),disinfectant ha...tment of,Management Services (DMS) in the State of...r, A World of Green, LLC(TM) ( http://www.aworldo...u(R) assigned under the code which now,permits Sta...
Other Medicine Technology:Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials 2Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 2Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |